Background {#Sec1}
==========

Ruptured abdominal aortic aneurysm (AAA) is an important cause of cardiovascular mortality in men over the age of 65 years \[[@CR1]\]. In Sweden, developed screening program had only a minor effect on AAA mortality \[[@CR2]\]. Currently, little is known about the pathobiology and underlying molecular mechanism of AAA, which limits the development of medical treatments to stabilize aneurysms. However, genetic component provides with a new orientation in the etiology of AAA. Determination of the aberrant genes related with AAA is an established approach to expanding the knowledge of the pathways contributing to aneurysmal degeneration of the abdominal aorta \[[@CR3]\].

Circular RNAs (circRNAs) represent a new type of endogenous non-coding RNAs produced by non-colinear reverse splicing. They are generated by an incorporation of the 3′ end and 5′ end and highly stable in vivo because of covalently closed loop structures \[[@CR4]\]. Numerous studies have determined that circRNAs can regulate transcriptional and post-transcriptional gene expression \[[@CR5], [@CR6]\]. The classic pathway is circRNA-miRNA (microRNA)-mRNA (messenger RNA), which indicates that circRNA binds and inhibits miRNA, subsequently affecting the target mRNA expression \[[@CR7], [@CR8]\]. Recently, circRNAs have been confirmed ideal candidates for diagnostic biomarkers and therapeutic targets in cardiovascular diseases \[[@CR9]--[@CR11]\]. Nevertheless, the circRNA expression profile and its potential regulative role in human AAA remain unclear.

In this study, we intended to identify the differentially expressed circRNAs between the AAA and the control group. Computational analysis was performed to predict the circRNA/miRNA interaction networks. Several dysregulated circRNAs expression levels were further testified by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR).

Methods {#Sec2}
=======

Patients {#Sec3}
--------

This study was approved by the Institutional Ethics Committees of Zhongshan Hospital, Fudan University (B2018-040R) and complied with the Declaration of Helsinki. From March 2018 to September 2018, 4 consecutive patients with AAA, who were unsuitable for endovascular repair, underwent open surgery at our center. All the 4 patients received computed tomography angiography examinations preoperatively and were not found with underlying connective tissue diseases. Written informed consent was obtained from all enrolled patients and donors next-of-kin. Full thickness AAA specimens were obtained from the aneurysmal segment of abdominal aorta and stored at − 80 °C until assayed. Over the same period, abdominal aortic samples just below the aortic trunk from 4 heart-beating brain-dead organ donors were used as the controls. Clinical characteristics and maximal infrarenal aortic diameter were recorded for patients with AAA, but this information was unavailable for donors (Table [1](#Tab1){ref-type="table"}). The median age of AAA patients and donors was 58.5 and 39 years, respectively (*P* = 0.057). Table 1Clinical characteristics of patients with abdominal aortic aneurysm and organ donorsPatient 1Patient 2Patient 3Patient 4Control 1Control 2Control 3Control 4SexMaleMaleMaleMaleMaleMaleMaleFemaleHypertension--+--+UUUUDiabetes--+----UUUUDyslipidemia--------UUUUCAD--------UUUUCOPD--------UUUURenal dysfunction--------UUUUStroke------+UUUUSmoking+--++UUUUMaximum abdominal aortic diameter (mm)61.765.159.756.0UUUUAortic neck diameter (mm)33.920.221.620.0UUUUProximal landing zone (mm)27.95.045.120.0UUUUAortic neck angulation (°)90301015UUUUAbbreviations: *CAD* coronary artery disease, *COPD* chronic obstructive pulmonary disease, *U* unclear

Microarray analysis {#Sec4}
-------------------

Total RNA of the 4 paired aortic samples were isolated using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). NanoDrop ND-1000 (NanoDrop Technologies, Wilmington, DE, USA) was utilized to assess the quality and quantification of the total RNA. The OD260/280 ratios of our samples were located between 1.8 and 2.1, which were acceptable. Then, RNA integrity and genomic DNA contamination were evaluated by electrophoresis on a denaturing agarose gel. RNase R (Epicentre Inc., Madison, WI, USA) was used to degrade the linear and ribosomal RNAs.

The enriched circRNAs were amplified and transcribed into fluorescence labeling complementary RNA (cRNA) (Arraystar, Rockville, MD, USA). RNeasy Mini Kit (Qiagen, Hilden, Germany) was applied to purify the labeled cRNAs. Subsequently, the fragmentation mixture, consisting of 1 μg of each labeled cRNA, 5 μl 10× blocking agent and 1 μl 25× fragmentation buffer, was incubated at 60 °C for 30 min. The fragmented labeled cRNAs were hybridized onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2). The slides were incubated for 17 h at 65 °C and then washed, fixed and scanned.

The scanned images were collected and imported into Agilent Feature Extraction software (Agilent Technologies Inc., CA, USA). Quantile normalization and subsequent data processing were carried out using the R software packages (R version 3.6.1, <https://www.r-project.org/>). Dysregulated circRNAs between 4 paired aortic samples were determined using the Limma package. The statistical significance was set as \|log~2~ fold change (FC)\| ≥ 1 with *P* value \< 0.05 estimated by t-test. A scatter plot and heat map were generated to assess the variation in circRNAs expression profiles between the AAA and the control group. The dysregulated circRNAs were showed via a Volcano Plot.

Computational bioinformatics analysis {#Sec5}
-------------------------------------

The interaction between aberrant circRNA and potential target microRNA was predicted by miRanda and TargetScan \[[@CR12], [@CR13]\]. Based on the prediction of miRNA binding sites, a circRNA/miRNA interaction network between circRNAs and 5 putative miRNA partners were constructed.

For the functional annotation of parental genes of the dysregulated circRNAs, the Database for Annotation, Visualization and Integrated Discovery (DAVID; <http://david.abcc.ncifcrf.gov/>) was utilized to conduct Gene Ontology (GO) analysis, including molecular function (MF), biological process (BP) and cellular component (CC). Further, pathway enrichment analysis was performed by Kyoto Encyclopedia of Genes and Genomes (KEGG) (<http://www.genome.jp/kegg/kegg2.html>) to detect the biological pathways of the involved parental genes \[[@CR14]\]. The significantly enriched GO terms (*P* value \< 0.05) were ranked by -log~10~ (*P* value).

qRT-PCR analysis {#Sec6}
----------------

The total RNA of 4 paired aortic samples was extracted using the Trizol reagent (Takara Bio Inc., Kusatsu, Japan). A Reverse Transcription kit (Takara Bio Inc.) was utilized to synthesize the complementary DNA. Circular RNAs of interest were amplified according to the manufacturer's protocol of SYBR-Green PCR Mix (Takara Bio Inc.). The PCR primer sequences are shown in Table [2](#Tab2){ref-type="table"}. β-actin was used as the internal control. The relative expression level of circRNAs was calculated using the 2^−ΔΔCT^ equation \[[@CR15]\]. Table 2Primers used for real-time quantitative reverse transcription-polymerase chain reactionGenesForward and reverse sequenceProduct length (bp)β-actinF:5′ GTGGCCGAGGACTTTGATTG3'R: 5′ CCTGTAACAACGCATCTCATATT3'73hsa_circ_0060063F:5′ TCTAAGGTGTCAGATGCCTGATAC 3′R:5′ TTCTCCACACAGCTAGTATACATGC 3'110hsa_circ_0070382F:5' TTCCCTACAAAGGACTCTCAGCAT 3′R:5′ ACTTCATTGGAGTAGGTCTGTTTGG 3'69hsa_circ_0005360F:5' AGCCAGCTCTGCGTGAACCT 3′R:5′ CGTTGTTGTCCAAGCATTCG 3'121hsa_circ_0002168F:5' GACCTACTTCTGCATCACCACAGTT 3′R:5′ TGTCAGCACCCCAGTGTACCA 3'80hsa_circ_0028198F:5' TCAAGACAAAGAACTCCCAAATGA 3′R:5′ AAGAGAGAATCTGCATGATACACCA 3'81hsa_circ_0027446F:5' CTGGAGAAAAACGGCCAAG 3′R:5′ TGCTGCCTTTGGGTCTTC 3'93Abbreviations: hsa, *Homo sapiens*; bp, base pair; F, forward; R, reverse

Statistical analysis {#Sec7}
--------------------

The relative expression level was compared by Student's t-test. Two tailed *P* value \< 0.05 was considered statistically significant. Statistical analyzes were carried out using Stata version 14.0 (StataCorp, College Station, Tex, USA).

Results {#Sec8}
=======

circRNA expression profiles {#Sec9}
---------------------------

To investigate the circRNA expression profiles in human AAA, we performed the high-throughput sequencing to identify the dysregulated circRNAs. In total, 13,295 circRNAs were detected. The box plot showed the nearly identical distributions of normalized intensity values from 4 paired aortic samples (Fig. [1](#Fig1){ref-type="fig"}a). A scatter plot visualized the variation of circRNA expression profile between the two groups (Fig. [1](#Fig1){ref-type="fig"}b). The volcano plot revealed significantly aberrant circRNAs with \|log~2~ FC\| ≥ 1 and *P* value \< 0.05 (Fig. [1](#Fig1){ref-type="fig"}c). Hierarchical clustering identified a distinct circRNA expression pattern among the samples (Fig. [1](#Fig1){ref-type="fig"}d). Finally, 411 circRNAs were observed differentially expressed, including 145 upregulated and 266 downregulated circRNAs in AAA. Based on the FC, the top 20 dysregulated circRNAs are summarized in Table [3](#Tab3){ref-type="table"}. Among these dysregulated circRNAs, 357(86.9%) circRNAs were found exonic. The circRNA distributions among the human chromosomes were also illustrated (Fig. [1](#Fig1){ref-type="fig"}e). Fig. 1circRNAs expression profiles detected by microarray in the AAA group and control group. **a** The box plot shows the nearly identical distributions of normalized intensity values from the aortic samples of the AAA and control group. **b** The scatter plot is built to assess the expression variation of circRNAs between the two groups. The X and Y axes indicate the normalized intensity values of each circRNAs from the AAA and control group. The dots above the upper green line and below the lower green line represent the dysregulated circRNAs with a fold change (FC) \> 2.0 between the two groups. **c** The volcano plot presents differentially expressed circRNAs in AAA. The vertical lines correspond to 2-fold upregulation and downregulation, the horizontal line indicates *P* value of 0.05. The red dots represent the differentially expressed circRNAs (FC \> 2.0 and *P* value \< 0.05). **d** Hierarchical clustering analysis reveals a distinguishable expression profile of circRNAs between the AAA and control group. Each column indicates an aortic sample, each row represents a circRNA. The red and green color indicate high and low expression level, respectively. **e** Chromosomal distribution of the differentially expressed circRNAs between the two groupsTable 3The top 20 dysregulated circRNAs in AAA group compared with control groupcircRNAGene SymbolRegulation*P*-valueFold Change (abs)chromhsa_circ_0001588HIST1H4Eup0.0148.04chr6hsa_circ_0000517RPPH1up0.0287.77chr14hsa_circ_0006156FNDC3Bup0.0076.66chr3hsa_circ_0000518RPPH1up0.0445.85chr14hsa_circ_0000524RBM23up0.0135.66chr14hsa_circ_0007148FNDC3Bup0.0125.65chr3hsa_circ_0068655UBXN7up0.0185.54chr3hsa_circ_0008285CDYLup0.0165.52chr6hsa_circ_0042268ATPAF2up0.0214.89chr17hsa_circ_0009361GNB1up0.0324.71chr1hsa_circ_0092291EIF2S2down0.0057.25chr20hsa_circ_0005073ADPGKdown0.0016.22chr15hsa_circ_0090069PHEXdown0.0065.99chrXhsa_circ_0057691SATB2down0.0035.30chr2hsa_circ_0003249LRP11down0.0064.67chr6hsa_circ_0092290SCRIBdown0.0124.49chr8hsa_circ_0092371PLEKHG4Bdown0.0184.38chr5hsa_circ_0027446HMGA2down0.0334.32chr12hsa_circ_0074306DIAPH1down0.0184.30chr5hsa_circ_0008554KANK2down0.0074.07chr19Abbreviations: *hsa Homo sapiens*, *chr* chromosome

Validation of dysregulated circRNAs {#Sec10}
-----------------------------------

To testify the results of microarray analysis, 6 dysregulated circRNAs (2 upregulated and 4 downregulated circRNAs), including hsa (*Homo sapiens*) \_circ_0060063 (UQCC1), hsa_circ_0070382 (AFF1), hsa_circ_0027446 (HMGA2), hsa_circ_0028198 (ANAPC7), hsa_circ_0005360 (LDLR) and hsa_circ_0002168 (TMEM189), were selected for further qRT-PCR validation. Compared with the control group, the expression level of hsa_circ_0005360 (LDLR) and hsa_circ_0002168 (TMEM189) were proved significantly lower in the AAA group (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Validation of six randomly selected dysregulated circRNAs by qRT-PCR. Each circRNA was evaluated at least three times and compared with the results of microarray. The Y axis indicates the fold change of AAA vs control of each circRNA

Functional analysis of parental genes {#Sec11}
-------------------------------------

For the upregulated circRNAs, the top 8 enriched GO terms were showed in Fig. [3](#Fig3){ref-type="fig"} and ranked by -log~10~ (*P* value). As a result, the most enriched MF, BP and CC terms were poly(A) RNA binding, negative regulation of transcription from RNA polymerase II promoter and nucleoplasm, respectively. Moreover, KEGG analysis presented that only one pathway significantly related to these upregulated circRNAs (*P* = 0.020), namely transcriptional misregulation in cancer. However, the downregulated circRNAs failed to be enriched in any GO terms or KEGG pathways. Fig. 3Gene ontology (GO) enrichment analysis for the parental genes of upregulated circRNAs. The X axis shows the top 8 GO terms in biological process, cellular component and molecular function corresponding to the upregulated circRNAs. The Y axis indicates log~10~ (*P* value)

miRNA prediction and competing endogenous RNA network construction {#Sec12}
------------------------------------------------------------------

circRNAs usually function as an inhibitor of their interacting miRNA partners. To assess the potential function of these dysregulated circRNAs, 5 putative miRNA partners were predicted for each circRNA. In total, 2055 circRNA/miRNA pairs having one or more binding regions were generated. Additionally, interaction networks between circRNA and their top 5 predicted miRNAs were constructed for the above qRT-PCR confirmed circRNAs (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4The predicted circRNA/miRNA interaction networks for six randomly selected circRNAs. **a**, **b** The red nodes indicate upregulated circRNAs. **c**-**f** The blue nodes represent downregulated circRNAs. The green nodes are five complementary binding miRNAs of each circRNA

Discussion {#Sec13}
==========

It is well established that AAAs are associated with smooth muscle cell apoptosis, local inflammatory cells infiltration, and extracellular matrix degradation in the aortic media layer at the aneurysm site \[[@CR3], [@CR16]--[@CR18]\]. Numerous clinical studies have confirmed that several traditional cardiovascular risk factors, such as gender, age, smoking, dyslipidemia and hypertension, lead to the development of AAAs \[[@CR19]--[@CR21]\]. However, the underlying molecular mechanisms responsible for the initiation and progression of AAAs remain unclear. Using gene expression profile, several researchers detected that immune and inflammatory response had a great impact on the pathogenesis of AAA \[[@CR22]--[@CR24]\]. Recently, advances in novel computational approaches and high-throughput sequencing techniques have sparked new interest in the research on noncoding RNAs \[[@CR25], [@CR26]\]. As an important member of noncoding RNAs, circRNAs are abundant, stable and highly conserved. Moreover, circRNAs can function as miRNA sponges and subsequently regulate gene expression, which increase our understanding of cardiovascular diseases research \[[@CR9], [@CR10]\]. Thus, we utilized high-throughput sequencing to analyze the circRNA expression profile between the AAA and control group.

In this study, we identified 411 differentially expressed circRNAs, of which 145 circRNAs were significantly upregulated and 266 circRNAs were significantly downregulated in AAA samples compared with controls. Six randomly selected circRNAs, including hsa_circ_0060063, hsa_circ_0070382, hsa_circ_0027446, hsa_circ_0028198, hsa_circ_0005360 and hsa_circ_0002168, were testified by qRT-PCR. The expression level of hsa_circ_0005360 and hsa_circ_0002168 were confirmed in accordance with the microarray analysis. Specially, the parental gene of hsa_circ_0005360 is LDLR, whose variant is proved associated with AAA in a genome-wide association study based on population \[[@CR27]\]. Moreover, LDLR-deficient mice infused with angiotensin II are widely used as animal models for AAA \[[@CR28]--[@CR30]\]. Considering that hsa_circ_0005360 is alternatively transcribed from exons of LDLR, hsa_circ_0005360 may have a potential role in AAA pathogenesis.

To further detect the regulative role of circRNAs in AAA, KEGG and GO analysis were performed for the functional annotation of parental genes. The most enriched MF, BP and CC terms were associated with poly(A) RNA binding, negative regulation of transcription from RNA polymerase II promoter and nucleoplasm, respectively. In addition, KEGG pathway analysis determined that transcriptional misregulation in cancer was the only significantly enriched pathway. These processes indicated that the parental genes of dysregulated circRNAs may participate in the transcriptional regulation of AAA. Similar with their parental gene function, circRNAs can also regulate transcriptional and posttranscriptional gene expression, especially functioning as miRNA sponges.

Previously, Zheng et al. found that hsa_circ_000595 was upregulated in human AAA tissues, which would reduce the expression of miR-19a and subsequently promote human vascular smooth muscle cells (VSMC) apoptosis \[[@CR31]\]. Similarly, apoptosis-related circRNAs were observed altered in AAA animal models \[[@CR26]\]. Besides, circWDR77/miR-124/FGF-2 and circSATB2/miR-939/STIM1 regulatory axis are verified to regulate VSMC proliferation and migration \[[@CR32], [@CR33]\]. In terms of other cell types in aorta, hsa_circ_0010729 was presented to regulate the apoptosis and proliferation of vascular endothelial cells by targeting the miR-186/HIF-1α axis \[[@CR34]\]. These findings suggest that circRNAs can bind to miRNAs and regulate gene expression at the posttranscriptional level, which contributes to a new dimension of knowledge on AAA pathogenesis. In this study, through matching conserved seed sequence, the circRNA/miRNA interaction networks were constructed according to miRNA binding sites. Among the circRNA/miRNA interaction networks, hsa_circ_0005360 and hsa_circ_0002168 harbors one binding site with miR-181b and miR-15a, respectively. Remarkably, miR-181b was determined highly expressed in human AAA and correlated with decreased expression of tissue inhibitor of metalloproteinase-3 and elastin, which promoted the progression of AAA \[[@CR28]\]. In addition, miR-15a was reported a negative regulatory role in the expression of CDKN2B and thus promoting the apoptosis of VSMC, which might lead to the pathogenesis of AAA \[[@CR35]\]. Further studies are warranted to confirm the hsa_circ_0005360/miR-181b and hsa_circ_0002168/miR-15a axis in AAA.

This study has several potential limitations. First, the sample size is relatively small and the results should be cautious to interpret. A multicenter study with large sample size may reduce the ethical biases and improve the reliability of the microarray data. Second, not all circRNAs function as the inhibitor of miRNAs. In fact, circRNAs can also interact with RNA-binding proteins, modulate transcription and alternative splicing, and even be translated, which are not mentioned in this study. Third, all the functional annotation of circRNAs and interaction networks were predicted based on bioinformatics analysis. Further experimental studies are warranted to clarify the potential mechanisms.

Conclusions {#Sec14}
===========

In summary, the dysregulated circRNAs identified by our study may have a regulative role in the initiation and progression of AAA. Additionally, circRNA/miRNA interaction networks provide new insights into the molecular mechanisms and potential therapeutic targets for AAA.
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